Home | Business News | Browse by Publication | B | Business Wire

Derma Sciences CEO Stresses Commitment to Manuka Honey for Wound Care at Comvita Ltd. Annual Meeting.

Article Excerpt
Comvita Ltd. Advances Its Global Wound Care Position with Acquisition of Australian-Based Medihoney Pty Ltd

PRINCETON, N.J. -- Derma Sciences, Inc. (OTCBB: DSCI), a manufacturer and supplier of wound and skin care products, announced that Chairman, President and CEO Edward J. Quilty spoke at the April 20, 2007 annual meeting of Comvita LTD, a New Zealand based natural health products company. Derma Sciences is Comvita Ltd.'s worldwide manufacturing and marketing partner for Active Manuka Honey based wound care products, manufacturing and marketing the Derma Sciences' API-MED brand in North, South, Central and Latin America, while manufacturing and marketing for the global market under the Comvita name. Quilty was introduced by Comvita's CEO Brett Hewlett and he discussed Derma's strategy before approximately 200 Comvita shareholders. Quilty's presence in New Zealand was in conjunction with his attendance at Comvita's global product launch conference where thought leaders from around the world discussed the antimicrobial and wound healing properties of Active Manuka Honey.

Quilty's comments at the Comvita annual meeting conveyed Derma Science's commitment to the Active Manuka Honey product line, stating that upon FDA clearance of Derma Sciences' Active...